Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: results of the German IGLU Follow-up Study 2001.

BACKGROUND To evaluate the factors influencing uterine size in young adult women with Turner syndrome (TS) after long-term growth hormone (GH) treatment. METHODS Cross-sectional study. Out of 188 women with TS from 96 German centres, whose longitudinal growth was documented within KIGS (Pfizer International Growth Database), data on uterine size were collected voluntarily at a standardized follow-up visit: 75 TS women (ages: 15.8-30.8 years) with complete data were included. Classification according to karyotype: 45,X (78.6%), 45,X/46,XX (5.4%), 45,X/46,iXq (8%), 45,X/46,XY (8%). Puberty was induced with estrogens in all women. At follow-up, 66 were on cyclic estrogens and progestins. RESULTS 13/66 (19.6%) TS women who received estrogens had a reduced uterine length <5 cm. Calculating the data in standard deviation scores (SDS), only women with 45,X/46,XX karyotype had normal median uterine length and volume of 0.6 and 1.59 SDS respectively. An incomplete breast development (Tanner stage B 3) was found in women with 45,X karyotype (n = 11; 18.6%) and with 45,X/46,XY (n = 2). CONCLUSIONS Only TS women with karyotype 45,X/46,XX had normal uterine sizes, whereas 26% of the TS women with karyotype 45,X had a uterine length <-2 SDS, and 18% a volume <-2 SDS.

[1]  M. Šnajderová,et al.  The Uterine Length in Women with Turner Syndrome Reflects the Postmenarcheal Daily Estrogen Dose , 2003, Hormone Research in Paediatrics.

[2]  D. Larizza,et al.  Pelvic ultrasound evaluation in patients with Turner syndrome during treatment with growth hormone , 2003, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[3]  C. McDonnell,et al.  A 3‐year prospective study to assess uterine growth in girls with Turner's syndrome by pelvic ultrasound , 2003, Clinical endocrinology.

[4]  M. Ranke,et al.  Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-up Study 2001. , 2002, European journal of endocrinology.

[5]  A. Hollman,et al.  Poor uterine development in Turner syndrome with oral oestrogen therapy , 2002, Clinical endocrinology.

[6]  M. Ranke,et al.  Prediction of Long-Term Response to Recombinant Human Growth Hormone in Turner Syndrome: Development and Validation of Mathematical Models , 2000 .

[7]  J. Frane,et al.  Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group. , 2000, The Journal of clinical endocrinology and metabolism.

[8]  J. Frane,et al.  Growth Hormone Therapy of Turner Syndrome: The Impact of Age of Estrogen Replacement on Final Height , 2000 .

[9]  L. Mazzanti,et al.  Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome. , 1999, The Journal of clinical endocrinology and metabolism.

[10]  M. Ranke,et al.  Pelvic ultrasonography in Turner syndrome: standards for uterine and ovarian volume. , 1999, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[11]  L. Mazzanti,et al.  Pelvic ultrasonography in patients with Turner syndrome: age-related findings in different karyotypes. , 1997, The Journal of pediatrics.

[12]  P. Hindmarsh,et al.  Growth of the uterus. , 1996, Archives of disease in childhood.

[13]  V. Pelzer.  [The value of ultrasonography in pediatric and adolescent gynecology]. , 1991, Der Gynakologe.

[14]  J. Adams,et al.  Ovarian ultrasound appearances in Turner syndrome. , 1989, The Journal of pediatrics.

[15]  G. Cutler,et al.  Ultrasonography of Turner's syndrome. , 1986, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[16]  K. Klein,et al.  Estradiol Levels in Girls with Turner's Syndrome Compared to Normal Prepubertal Girls as Determined by an Ultrasensitive Assay , 2003, Journal of pediatric endocrinology & metabolism : JPEM.

[17]  M. Ranke,et al.  Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study. , 2000, The Journal of clinical endocrinology and metabolism.

[18]  U. Tuschy.  Spontaneous growth in Turner's syndrome. , 1990, Padiatrie und Grenzgebiete.

[19]  D. Babcock.  Neonatal and pediatric ultrasonography. , 1989, Clinics in diagnostic ultrasound.